An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

BACKGROUND: Estrogen receptor (ER)-negative breast cancer specimens are predominantly of high grade, have frequent p53 mutations, and are broadly divided into HER2-positive and basal subtypes. Although ER-negative disease has overall worse prognosis than does ER-positive breast cancer, not all ER-ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Teschendorff, Andrew E, Miremadi, Ahmad, Pinder, Sarah E, Ellis, Ian O, Caldas, Carlos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374988/
https://www.ncbi.nlm.nih.gov/pubmed/17683518
http://dx.doi.org/10.1186/gb-2007-8-8-r157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374988/
https://www.ncbi.nlm.nih.gov/pubmed/17683518
http://dx.doi.org/10.1186/gb-2007-8-8-r157

Ejemplares similares